What is the Found Medicare GLP-1 Bridge program?

It is a Found program for adults aged 65–75 with Medicare Part D drug coverage. Rather than selling you a cash-pay compounded GLP-1, Found runs the medication through your existing Part D plan: its team verifies your plan, files and tracks the prior authorization, and you pay a medication copay advertised at $50/month instead of the roughly $198/month Found shows as the comparison figure. Covered options are Zepbound, Wegovy or Foundayo.

How much does the Found Medicare GLP-1 Bridge cost in total?

Found advertises a total starting at $99/month: a $50/month medication copay plus Found membership starting at $49/month when billed annually. The 12-month plan carries the best price. Found states that medication coverage and copays vary based on eligibility and insurance approval, so $50 is a starting figure rather than a fixed rate for every plan.

Who is eligible for the Found Medicare Bridge?

Found frames eligibility around three things: age 65–75, active Medicare Part D drug coverage, and clinical appropriateness as judged by a board-certified clinician. There is a free eligibility check that takes about three minutes with no commitment, and Found says it verifies your plan and files the paperwork before you pay anything. Whether your specific plan approves the medication is the part neither you nor Found controls.

Does Medicare actually cover GLP-1s for weight loss?

Not for weight loss alone. Medicare Part D is barred by statute from covering drugs used for weight reduction, which is why a program like this exists in the first place. What Part D plans can cover is a GLP-1 prescribed for an approved non-obesity indication — Wegovy is FDA-approved to reduce cardiovascular death, heart attack and stroke in adults with cardiovascular disease plus obesity or overweight, and Zepbound is FDA-approved for moderate-to-severe obstructive sleep apnea in adults with obesity. A qualifying diagnosis is generally what makes coverage possible, and that is what the clinician review is establishing.

Which medications are covered under the Bridge?

Found lists Zepbound, Wegovy and Foundayo. Zepbound (tirzepatide) and Wegovy (semaglutide) are FDA-approved branded medications from their manufacturers. Foundayo is Found’s own branded medication option — if a clinician steers you toward it rather than one of the two branded GLP-1s, ask specifically what it contains and how it is dispensed before you agree.

How long does it take to get started with Found?

Found describes a four-step process that runs entirely online: a three-minute health assessment, clinician review within one to two days, medication prepared by a licensed pharmacy and shipped to your door, then monthly clinician check-ins. Insurance verification and prior authorization are handled by Found’s team in parallel, which is the slowest part of any Part D approval and the main reason a start date can slip.

What support do you get beyond the prescription?

Found includes ongoing clinician support and prescription management in the membership: board-certified clinicians trained in obesity care, monthly check-ins to keep the dose optimized, side-effect support in the app, easy refills, and messaging with your care team between visits. Found publishes named clinicians with individual patient ratings — Dr. Jennifer Wetherington (4.91), Dr. Molly Middleton (4.93), Kai Lehardi NP (4.87) and Gem Escamilla NP (4.85).

Can I use the Bridge if I already take a GLP-1?

Found flags this as a common question and handles it in the eligibility check rather than publishing a blanket rule. If you are already on a GLP-1 — cash-pay compounded or branded — bring your current medication and dose to the assessment, since continuing an existing dose through a new plan is a different approval path from starting fresh. The clinician review determines what is appropriate.

Is there a commitment or cancellation fee?

The eligibility check itself is free with no commitment, and Found says it verifies coverage before you pay anything. The membership is a subscription, and the $49/month rate depends on annual billing, so the cheapest advertised price does involve a 12-month term. Read Found’s refund policy, payment and billing consent, and offer terms before enrolling to confirm what happens if you cancel mid-term.

GLP-1 Weight Loss Review

Found Medicare GLP-1 Bridge Review (2026): Zepbound and Wegovy at a $50 Copay

Q: What results does Found report?

Found reports 300,000+ members, 1.4 million pounds lost, a 4.89 average rating, average weight loss of about 12% of body weight over one year across 1,773 tracked users, 83% of members sustaining results at one year, and more than 80% reporting zero side effects on starting. These are company-reported figures, not independent trial results, and Found notes individual results vary. Published trial data for Wegovy and Zepbound sits in the 15–20% range at the highest doses.

Found runs branded, FDA-approved Zepbound or Wegovy through your existing Medicare Part D plan for adults 65–75 — filing the prior authorization itself so the copay lands near $50/month instead of ~$650 cash.

Branded Zepbound®/Wegovy® — not a compounded substitute
$50/mo advertised medication copay through Part D
Prior authorization filed and tracked by Found
Free 3-minute eligibility check, ages 65–75

8.8

Branded GLP-1s through Part D, near $99/mo

From $99/mo all-in ($50 copay + $49 membership)

Ages 65–75 with active Medicare Part D · Coverage depends on a qualifying diagnosis

By Charly P. · Not medically reviewed · 12 min read

Published August 2026 · Pricing last checked August 2026

Branded FDA-approved GLP-1s
$50/mo copay via Part D
Named board-certified clinicians
Free eligibility check

Affiliate Disclosure: This article contains affiliate links. A commission may be earned at no additional cost to you.

Found has built something the rest of the GLP-1 telehealth market has largely skipped: a program for adults aged 65 to 75 that runs branded medication through Medicare Part D instead of selling around it. The Medicare GLP-1 Bridge covers Zepbound®, Wegovy® or Foundayo™ at an advertised $50/month copay, with Found's team verifying your plan and filing the prior authorization before you pay anything. Add membership from $49/month and the total starts at $99/month — against roughly $650/month for branded Zepbound or Wegovy paid in cash. If you qualify, the math is not close. Our best weight loss treatments guide covers how the rest of the market prices the same medications without insurance in the picture.

Found Medicare GLP-1 Bridge at a Glance

Program	Found Medicare GLP-1 Bridge
Who It Is For	Adults aged 65–75 with Medicare Part D drug coverage
Medication Copay	$50/month advertised (compared against $198/month)
Found Membership	From $49/month when billed annually
Total Starting Price	From $99/month; best price on the 12-month plan
Medications Covered	Zepbound®, Wegovy®, or Foundayo™
Insurance	Runs through your existing Medicare Part D drug plan
Paperwork	Prior authorization filed and tracked by Found’s team
Eligibility Check	Free, about 3 minutes, no commitment
Clinician Review	Board-certified clinicians, 1–2 days
Ongoing Care	Monthly clinician check-ins, in-app side-effect support, messaging
Fulfillment	Licensed pharmacy, shipped to your door
Company Scale	300,000+ members, 1.4M lbs lost, 4.89 average rating
Reported Results	~12% average body weight loss at 1 year (1,773 tracked users)

See If You Qualify for the $50 Copay →

What Is the Found Medicare GLP-1 Bridge?

The Bridge is a distribution route, not a new drug — Found's existing telehealth platform billing the medication to your existing Part D plan instead of selling around it, with Found handling the administrative work that normally makes that impossible to pull off alone.

What Found normally sells	Compounded GLP-1s from ~$99/month, or branded from ~$650/month in cash
What the Bridge adds	A 4th path: medication billed to your Part D plan, Found files the paperwork
Prior authorization	A documentation exercise — qualifying diagnosis, clinical rationale, evidence of prior treatment. Found’s team files and tracks it start to finish, and verifies your plan before you pay
Clinical approach for ages 65–75	At-home visits; a plan built around starting a GLP-1 later in life — dose titration, muscle preservation and drug interactions weighted differently than a protocol reused from younger patients

Start Your Free Found Eligibility Check →

How Medicare Part D Coverage Actually Works Here

Medicare Part D is barred by statute from covering drugs used for weight reduction. That exclusion has not been repealed, which is precisely why a program needs to exist to bridge the gap — and why the name is honest.

Update, August 2026: CMS launched its own Medicare GLP-1 Bridge demonstration on July 1, 2026, which pays for GLP-1s prescribed for weight loss itself at a flat $50 copay and sits outside the Part D benefit. Its criteria are BMI-based, and a cardiovascular, sleep-apnea or type 2 diabetes diagnosis routes you to standard Part D coverage rather than the demonstration. Found now runs the federal Bridge for the 65–75 band; see Found Health’s Medicare Part D GLP-1 announcement for what changed.

What Part D plans can cover is a GLP-1 prescribed for an approved indication that is not weight loss. Two exist:

Wegovy — approved to reduce cardiovascular death, heart attack and stroke in adults with established cardiovascular disease plus obesity or overweight, per the FDA (trial: major adverse cardiovascular events in 6.5% on Wegovy vs. 8% on placebo).
Zepbound — approved for moderate-to-severe obstructive sleep apnea in adults with obesity, granted by the FDA in December 2024 as the first medication for OSA.

Cardiovascular disease and sleep apnea are both common in adults aged 65–75 carrying excess weight, and many already have a documented diagnosis on file — which is what the clinician review is checking for. If neither applies, Part D coverage is unlikely regardless of how well the paperwork is filed.

Found states plainly that medication coverage and copays vary based on eligibility and insurance approval. Treat $50/month as a starting copay, not a guaranteed price: Part D plans differ in formulary tier, deductible and coverage phase, and your out-of-pocket cost can move across the plan year. Confirm your specific copay with Found before your first shipment.

Have Found Verify Your Part D Plan →

Found Medicare Bridge Pricing

Found splits the price into two visible lines, which is the right way to publish it — the medication and the service are billed by different parties and behave differently.

Line Item	Cost	What It Covers
Medication copay	$50/month	Zepbound®, Wegovy® or Foundayo™ billed through your Part D plan
Found membership	From $49/month	Insurance paperwork, ongoing clinician support, prescription management
Total	From $99/month	Best rate requires the 12-month plan, billed annually

Set against branded cash pricing, the gap is the entire argument for this program:

Branded cash price: Wegovy/Zepbound ~$650/month; Ozempic/Mounjaro ~$1,100/month.
Found Medicare Bridge: ~$99/month all-in — roughly a sixth of the branded cash price, for an FDA-approved (not compounded) drug.
Compounded alternatives with no insurance or eligibility hurdle: altRx from $89/month, HumeCare+ from $199/month.

The Bridge wins when you want the branded, FDA-approved drug and have a Part D plan that can be made to pay for most of it.

The $49/month membership rate depends on annual billing, so the advertised $99/month total assumes a 12-month commitment. Check Found's refund policy and offer terms for what happens if you cancel mid-term or if your plan denies coverage after you have enrolled.

See Your Total Monthly Cost with Found →

How the Found Medicare Bridge Works

Four steps, entirely online, from eligibility check to medication at your door.

1.
Take a 3-Minute Health Assessment
Found says the questions were built by the same licensed clinicians who review your case, and that by the end you will have a sense of which medication fits before checkout. This is also the free eligibility check — no commitment, and Found verifies your plan before you pay anything.
2.
A Board-Certified Clinician Reviews Your Profile (1–2 Days)
A clinician, not an algorithm, evaluates whether GLP-1 medication is medically appropriate for you. For the Medicare route this review also establishes the clinical picture the prior authorization will rest on. If approved, your prescription is written.
3.
Found Files the Paperwork and Your Medication Ships
Found’s team files and tracks the prior authorization with your Part D plan start to finish. Once approved, the medication is prepared by a licensed pharmacy and shipped to your door.
4.
Ongoing Care That Adapts
Monthly clinician check-ins keep your dose optimized as you titrate. Refills are handled for you, side-effect support lives in the app, and you can message your care team between visits.

Begin the 3-Minute Found Assessment →

The Care Team

Found does something most telehealth platforms avoid: it names the clinicians and publishes their individual patient ratings. Every Found clinician is described as board-certified and trained in obesity care.

Dr. Molly Middleton, MD	Family & obesity medicine — 4.93 patient rating
Dr. Jennifer Wetherington, MD	Family & lifestyle medicine — 4.91 patient rating
Kai Lehardi, NP	Family medicine — 4.87 patient rating
Gem Escamilla, NP	Family medicine — 4.85 patient rating

Named clinicians with visible ratings are an accountability signal, and one that is easy for a competitor to copy and telling that so few do. Note that these are Found's own patient ratings rather than an independent registry, and that you will not necessarily be assigned any specific person on the list.

Get Matched with a Found Clinician →

What Results Does Found Report?

Found publishes more outcome data than most of the category, and the figures are notably restrained — which, oddly, makes them more credible.

Tracked users	1,773
Average weight loss at 1 year	~12% of body weight
Sustaining results at 1 year	83% of members
Zero side effects on starting	>80% of members
Platform-wide members	300,000+
Platform-wide pounds lost	1.4 million
Platform-wide average rating	4.89
Pivotal trial range (Wegovy/Zepbound, highest doses)	15–20%

Found's 12% sits below that trial range, and it says so itself rather than quoting the trial ceiling as an expected result — real-world averages typically land under trial averages because adherence, titration pace and dose vary outside a study protocol. Publishing the lower, real number is a useful signal about how a provider sets expectations.

All of the above is company-reported data, not independent trial evidence. Found notes individual results vary and that meaningful progress typically takes two to three months. Sustainable change on a GLP-1 is a multi-month process regardless of provider.

See What Found Can Do for You →

Found Medicare GLP-1 Bridge Pros and Cons

Pros

Branded, FDA-approved medication — Zepbound® and Wegovy®, not a compounded substitute
$50/month advertised medication copay against roughly $650/month cash for the same drugs
Total from $99/month including membership on the 12-month plan
Prior authorization filed and tracked by Found — the hardest part of Part D coverage, outsourced
Free eligibility and plan verification before you pay anything, in about 3 minutes
Program designed for the 65–75 age band rather than repurposed from a younger protocol
Named board-certified clinicians with published patient ratings, monthly check-ins
Company-reported results are restrained and specific (~12% at one year, 1,773 users tracked)

Cons

Narrow eligibility — ages 65–75 with active Medicare Part D coverage only
Part D cannot cover a GLP-1 for weight loss alone; coverage generally requires a qualifying diagnosis such as cardiovascular disease or obstructive sleep apnea
$50 is a starting copay — Found states coverage and copays vary by eligibility and insurance approval
The $99/month total assumes annual billing on a 12-month plan
Approval timing depends on your plan, so a start date can slip beyond the 1–2 day clinician review
Foundayo™ is Found’s own branded option rather than a manufacturer GLP-1 — ask what it contains
GLP-1 medications carry serious risks, including a boxed warning for thyroid C-cell tumors

Check Eligibility Free — No Commitment →

How the Bridge Compares to Cash-Pay GLP-1 Programs

The right comparison depends entirely on whether you can use insurance. Here is how the Bridge lines up against three cash-pay routes we have reviewed:

Route	Monthly Cost	Medication
Found Medicare Bridge	From $99 all-in	Branded Zepbound®/Wegovy®, FDA-approved
Found cash-pay branded	From ~$650	Branded Zepbound®/Wegovy®, FDA-approved
HumeCare+	$199 semaglutide / $299 tirzepatide	Compounded, not FDA-approved
altRx	$89 semaglutide / $149 tirzepatide	Compounded, not FDA-approved

If you clear the eligibility bar: nothing else on the market gets you branded, FDA-approved medication near $99/month — the Bridge occupies a lane by itself rather than competing on price.
If you don't clear it: a compounded provider such as Measured is cheaper and faster to start, at the cost of a product the FDA has not reviewed.
If injections are the sticking point: Found's own oral GLP-1 program is a third option.

Compare the Bridge on Found's Official Site →

Who Should Use the Found Medicare Bridge?

Good fit if you...

✓Are aged 65–75 on Medicare Part D and already know a GLP-1 would help
✓Have a cardiovascular diagnosis or diagnosed sleep apnea alongside excess weight in your chart
✓Have been avoiding the prior-authorization paperwork — having a team file and track it is worth the membership fee on its own

Skip it if...

✗You are outside the 65–75 age band
✗You have no Part D drug coverage
✗Weight loss is your only clinical indication with nothing else in your chart to support coverage

In any of those skip cases, a cash-pay compounded program will get you treated faster — see the 2026 weight loss treatment comparison.

See If You Qualify in About 3 Minutes →

Safety and Medical Oversight

Every prescription runs through a board-certified clinician trained in obesity care, with monthly check-ins to adjust dose and in-app side-effect support between visits. Because the Bridge dispenses branded Zepbound and Wegovy through a licensed pharmacy, you are getting an FDA-approved finished product with a full label — a meaningful safety advantage over compounded alternatives.

Important safety note: GLP-1 receptor agonists carry serious risks, including a boxed warning for thyroid C-cell tumors and medullary thyroid carcinoma. Report any lump or swelling in the neck, hoarseness, trouble swallowing or shortness of breath to your provider. Older adults starting a GLP-1 should also discuss muscle mass, hydration, and interactions with existing prescriptions — a longer medication list is the norm at this age and is exactly what the clinician review exists to catch.

Talk to a Found Clinician About Your Medications →

How We Scored Found

Our 8.8/10 is a weighted mean of six categories, scored in August 2026 using the same criteria we apply to every GLP-1 provider. Where we could not verify a claim, the category is capped rather than given full marks.

How We Scored It

8.8

Branded GLP-1s through Part D, near $99/mo

Pricing transparency(25%)9.0

Two clearly separated lines ($50 copay + $49 membership) with the caveat that copays vary by plan stated up front.

Medical safeguards(20%)9.0

Branded, FDA-approved Zepbound/Wegovy dispensed by a licensed pharmacy, prescribed by board-certified clinicians.

Service & support(15%)9.0

The prior-authorization filing is the product; monthly check-ins, refills, and in-app support are bundled in.

Customer experience & evidence(15%)8.5

Restrained, specific company-reported outcomes (~12% at one year) rather than quoting the trial ceiling.

Availability & convenience(15%)8.0

Fully online, but eligibility is narrow — ages 65–75 with Part D and a qualifying diagnosis — and approval timing can slip.

Reputation & supporting evidence(10%)9.0

Named board-certified clinicians with published ratings and 300,000+ members across the platform.

The same weighted method is applied to every provider we score, so competitor ratings are comparable. See our best weight loss treatments guide.

Found Alternatives

Not eligible for the Bridge, or want to compare before you check? The closest single comparison to this program is IVIM Health, whose review covers the intake, the clinician model and what you pay at renewal. Here are the top-rated GLP-1 weight loss programs we recommend:

Recommended Providers

Our editorial team’s top picks for this category.

9.9★Visit Site →

9.8★Visit Site →

9.7★Visit Site →

Frequently Asked Questions

9.9★Visit Site →

9.8★Visit Site →

9.7★Visit Site →

Have More Questions? Visit the Official Found Website →

Bottom Line

Our Editorial Take

The Medicare GLP-1 Bridge is the most interesting thing Found has launched, because it solves a problem money alone cannot. Adults aged 65 to 75 are among the people most likely to benefit from a GLP-1 and least likely to be able to afford one out of pocket, and the barrier has never been the prescription — it has been the prior authorization. Found took the administrative burden onto itself and priced the result at $99/month all-in for branded, FDA-approved medication. Nothing else in this market does that.

The honest limit is eligibility. Medicare Part D still cannot cover a GLP-1 for weight loss alone, so the program works through the cardiovascular and sleep apnea indications the FDA has approved — which means your chart, not your intent, decides whether the $50 copay is available. Found is upfront that coverage and copays vary, and the free three-minute check gives you the answer without spending anything. Worth checking if you are 65 to 75 on Part D, particularly with a cardiovascular or sleep apnea diagnosis on file; not worth pursuing if you fall outside the age band, lack Part D coverage, or have no qualifying indication. Overall: 8.8/10.

Branded Zepbound/Wegovy at a $50/mo copay · From $99/mo all-in

Check Your Free Found Eligibility Now →

Free 3-minute eligibility check · Ages 65–75 with Medicare Part D

Advertising & Affiliate Disclosure: We may receive compensation when you click on links to partners featured on this site. Our rankings and recommendations are based on our independent research methodology and editorial standards, not on sponsorship or payment. Some links are affiliate links, which means we may earn a commission at no extra cost to you if you make a purchase.

Medical Disclaimer: The content on this site is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider for medical questions, treatment decisions, or emergency care. Do not disregard professional medical advice or delay seeking it based on information found here.